These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 30277820

  • 1. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition.
    Wu D, Kanda A, Liu Y, Kase S, Noda K, Ishida S.
    FASEB J; 2019 Feb; 33(2):2498-2513. PubMed ID: 30277820
    [Abstract] [Full Text] [Related]

  • 2. αB-Crystallin Regulates Subretinal Fibrosis by Modulation of Epithelial-Mesenchymal Transition.
    Ishikawa K, Sreekumar PG, Spee C, Nazari H, Zhu D, Kannan R, Hinton DR.
    Am J Pathol; 2016 Apr; 186(4):859-73. PubMed ID: 26878210
    [Abstract] [Full Text] [Related]

  • 3. The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis.
    Zhang R, Liu Z, Zhang H, Zhang Y, Lin D.
    PLoS One; 2016 Apr; 11(1):e0146808. PubMed ID: 26760305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration.
    Ma X, Takahashi Y, Wu W, Chen J, Dehdarani M, Liang W, Shin YH, Benyajati S, Ma JX.
    FASEB J; 2021 Dec; 35(12):e22058. PubMed ID: 34820908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adrenomedullin-Receptor Activity-Modifying Protein 2 System Ameliorates Subretinal Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Age-Related Macular Degeneration.
    Tanaka M, Kakihara S, Hirabayashi K, Imai A, Toriyama Y, Iesato Y, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Tanaka M, Cui N, Wei Y, Zhao Y, Aruga K, Yamauchi A, Murata T, Shindo T.
    Am J Pathol; 2021 Apr; 191(4):652-668. PubMed ID: 33385343
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells.
    Llorián-Salvador M, Byrne EM, Szczepan M, Little K, Chen M, Xu H.
    J Neuroinflammation; 2022 Jul 14; 19(1):182. PubMed ID: 35831910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
    Li Y, Liu X, Zhou T, Kelley MR, Edwards P, Gao H, Qiao X.
    Redox Biol; 2014 Jul 14; 2():485-94. PubMed ID: 24624338
    [Abstract] [Full Text] [Related]

  • 19. Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration.
    Little K, Llorián-Salvador M, Tang M, Du X, Marry S, Chen M, Xu H.
    J Neuroinflammation; 2020 Nov 25; 17(1):355. PubMed ID: 33239022
    [Abstract] [Full Text] [Related]

  • 20. Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor.
    Kobayashi M, Tokuda K, Kobayashi Y, Yamashiro C, Uchi SH, Hatano M, Kimura K.
    Invest Ophthalmol Vis Sci; 2019 Feb 01; 60(2):528-537. PubMed ID: 30707754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.